Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer.

The efficacy of high-dose chemotherapy (HDC) and circulating progenitor cell (CPC) transplantation in metastatic breast cancer (MBC) relies mainly on giving this treatment after a response to conventional induction chemotherapy has been achieved. For this reason an optimal mobilization regimen shoul...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedrazzoli, P., Perotti, C., Da Prada, G. A., Bertolini, F., Gibelli, N., Torretta, L., Battaglia, M., Pavesi, L., Preti, P., Salvaneschi, L., Robustelli della Cuna, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228223/
https://www.ncbi.nlm.nih.gov/pubmed/9155060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228223/
https://www.ncbi.nlm.nih.gov/pubmed/9155060

Ejemplares similares